NCT07467772 2026-03-12Ph 2 Elacestrant in ER Positive Uterine SarcomasDana-Farber Cancer InstitutePhase 2 Not yet recruiting30 enrolled
NCT05963997 2026-01-16SUMIT-ELACarrick Therapeutics LimitedPhase 1/2 Active not recruiting49 enrolled